Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Indiana U. Expert Says Nation's Physicians Support National Health Insurance
President Barack Obama spoke to the American Medical Association (AMA) recently addressing concerns about health insurance reform and the whole nation, including physicians from coast to coast, listened.
generic viagra online
ImmunoGen, Inc. Announces Encouraging Trastuzumab-DM1 Phase II Clinical Findings Presented At ASCO
ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced the presentation of encouraging trastuzumab-DM1 (T-DM1) clinical data at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Orlando, Florida.
News of the day
Ongoing Study Shows That Endovascular Therapy Is Associated With High Cure Rate For Childhood Eye Cancer
Expanded results of a study conducted on children with eye cancer (retinoblastoma) shows that chemotherapy delivered through endovascular (through the vessel) means not only successfully cures the cancer in a majority of cases, but achieves this cure with preserved vision. Study outcomes were presented this week at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL by lead author Pierre Gobin, Professor of Radiology in Neurosurgery and Neurology at the Weill Cornell Medical Center at New York Presbyterian Hospital in New York City.
Health Insurance

BIO Commends NIH On New Stem Cell Research Guidelines

The Biotechnology Industry Organization released the following statement in response to the National Institutes of Health"s (NIH) final guidelines on federal funding of stem cell research, which includes embryonic stem cell research. The new guidelines go into effect today. These comments can be attributed to Jim Greenwood, President and CEO of BIO. "We commend the NIH for recognizing the importance of stem cell research to develop innovative biotechnology medicines to treat and cure debilitating and life-threatening diseases, such as diabetes, Parkinson"s and spinal cord injuries. "These guidelines allow for federal funding to support this research, which is critical for enabling biotechnology companies to continue to aggressively develop innovative products that are so desperately needed by patients. We believe that research on both adult and embryonic stem cells holds great promise to produce new therapies and possibly cures for the millions of patients in the U.S. and around the world suffering from cancer, diabetes, Alzheimer"s, Parkinson"s, spinal cord injuries and other life-threatening diseases and conditions. "We applaud President Obama for taking the first major step by issuing an Executive Order on March 9th overturning restrictions placed on federal funding of embryonic stem cell research. We look forward to working with Congress and the Administration to develop public policies that enable our industry to turn the hope of basic research to the reality of cures and advanced therapies." The guidelines can be viewed here. Biotechnology Industry Organization


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009